05:59 GMT23 September 2020
Listen Live
    World
    Get short URL
    0 160
    Subscribe

    MOSCOW (Sputnik) - Russian pharmaceutical company R-Pharm agreed with AstraZeneca to produce Oxford vaccine against COVID-19 in Russia, including for its subsequent export to 30-50 countries, R-Pharm founder and board chairman, Alexey Repik, said on Friday.

    "We formalized our intention in the form of a signed agreement on the production and supply of a vaccine developed by AstraZeneca and Oxford University, using R-Pharm’s technological capabilities to implement the project. Moreover, R-Pharm will act as a kind of hub for vaccine supplies to a huge number of countries — to 30-50 countries, including the Middle East, including Southeast Asia, Europe, naturally the CIS, and naturally Russia ... Naturally, Russia is always a top priority for us," Repik told the Rossiya 24 broadcaster.

    Tags:
    export, AstraZeneca, vaccine, COVID-19, Russia
    Community standardsDiscussion